39 related articles for article (PubMed ID: 27273941)
1. Developing and Validating a Survival Prediction Model for NSCLC Patients Through Distributed Learning Across 3 Countries.
Jochems A; Deist TM; El Naqa I; Kessler M; Mayo C; Reeves J; Jolly S; Matuszak M; Ten Haken R; van Soest J; Oberije C; Faivre-Finn C; Price G; de Ruysscher D; Lambin P; Dekker A
Int J Radiat Oncol Biol Phys; 2017 Oct; 99(2):344-352. PubMed ID: 28871984
[TBL] [Abstract][Full Text] [Related]
2. The Effect of Microwave Ablation Combined with Anti-PD-1 Monoclonal Antibody on T Cell Subsets and Long-Term Prognosis in Patients Suffering from Non-Small-Cell Lung Cancer.
Yu W; Sun J; Wang T; Du Y
Comput Math Methods Med; 2022; 2022():7095423. PubMed ID: 36199771
[TBL] [Abstract][Full Text] [Related]
3. Evidence mounts for the efficacy of radioimmunotherapy for B-cell lymphomas.
Press OW
J Clin Oncol; 2008 Nov; 26(32):5147-50. PubMed ID: 18854559
[No Abstract] [Full Text] [Related]
4. Radioimmunotherapy With WT1 Dendritic Cell Vaccine for End-Stage Lung Adenocarcinoma Markedly Shrinks Tumors.
Nagai H; Karube R; Zhao F
Cureus; 2023 Nov; 15(11):e48412. PubMed ID: 38074069
[TBL] [Abstract][Full Text] [Related]
5. Randomized Phase II Study of Docetaxel plus Personalized Peptide Vaccination versus Docetaxel plus Placebo for Patients with Previously Treated Advanced Wild Type EGFR Non-Small-Cell Lung Cancer.
Takayama K; Sugawara S; Saijo Y; Maemondo M; Sato A; Takamori S; Harada T; Sasada T; Kakuma T; Kishimoto J; Yamada A; Noguchi M; Itoh K; Nakanishi Y
J Immunol Res; 2016; 2016():1745108. PubMed ID: 27274999
[TBL] [Abstract][Full Text] [Related]
6. Survival outcomes for surgical resection versus CT-guided percutaneous ablation for stage I non-small cell lung cancer (NSCLC): a systematic review and meta-analysis.
Chan MV; Huo YR; Cao C; Ridley L
Eur Radiol; 2021 Jul; 31(7):5421-5433. PubMed ID: 33449192
[TBL] [Abstract][Full Text] [Related]
7. Carrier systems of radiopharmaceuticals and the application in cancer therapy.
Zhang T; Lei H; Chen X; Dou Z; Yu B; Su W; Wang W; Jin X; Katsube T; Wang B; Zhang H; Li Q; Di C
Cell Death Discov; 2024 Jan; 10(1):16. PubMed ID: 38195680
[TBL] [Abstract][Full Text] [Related]
8. The efficacy and safety of thermal ablation for patients with lung malignancy: a meta-analysis of 12 studies in China.
Liu R; Shen Q; Lu H
J Cardiothorac Surg; 2022 Dec; 17(1):334. PubMed ID: 36550584
[TBL] [Abstract][Full Text] [Related]
9. Effect of Comprehensive Nursing Intervention on the Effect of CT-Guided Intravenous Thrombolysis in Acute Cerebral Infarction.
Sun Z; Jiang H; Chen C; Fan Y
J Healthc Eng; 2022; 2022():6959416. PubMed ID: 35083027
[TBL] [Abstract][Full Text] [Related]
10. Radioimmunotherapy in Oncology: Overview of the Last Decade Clinical Trials.
Rondon A; Rouanet J; Degoul F
Cancers (Basel); 2021 Nov; 13(21):. PubMed ID: 34771732
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-98-5p inhibits proliferation and metastasis in non-small cell lung cancer by targeting TGFBR1.
Jiang F; Yu Q; Chu Y; Zhu X; Lu W; Liu Q; Wang Q
Int J Oncol; 2019 Jan; 54(1):128-138. PubMed ID: 30387848
[TBL] [Abstract][Full Text] [Related]
12. Induction chemoradiation in stage IIIA/N2 non-small-cell lung cancer: a phase 3 randomised trial.
Pless M; Stupp R; Ris HB; Stahel RA; Weder W; Thierstein S; Gerard MA; Xyrafas A; Früh M; Cathomas R; Zippelius A; Roth A; Bijelovic M; Ochsenbein A; Meier UR; Mamot C; Rauch D; Gautschi O; Betticher DC; Mirimanoff RO; Peters S;
Lancet; 2015 Sep; 386(9998):1049-56. PubMed ID: 26275735
[TBL] [Abstract][Full Text] [Related]
13. Concurrent cetuximab and radiotherapy after docetaxel-cisplatin induction chemotherapy in stage III NSCLC: satellite--a phase II study from the Swedish Lung Cancer Study Group.
Hallqvist A; Wagenius G; Rylander H; Brodin O; Holmberg E; Lödén B; Ewers SB; Bergström S; Wichardt-Johansson G; Nilsson K; Ekberg L; Sederholm C; Nyman J
Lung Cancer; 2011 Feb; 71(2):166-72. PubMed ID: 20541833
[TBL] [Abstract][Full Text] [Related]
14. Early-stage non-small-cell lung cancer: current perspectives in combined-modality therapy.
Bunn PA
Clin Lung Cancer; 2004 Sep; 6(2):85-98. PubMed ID: 15476594
[TBL] [Abstract][Full Text] [Related]
15. Neoadjuvant chemoradiotherapy followed by surgery for stage IIIa and IIIb non-small-cell lung cancer (NSCLC): is it still justified?
Mirimanoff RO
Chin Clin Oncol; 2015 Dec; 4(4):49. PubMed ID: 26730761
[TBL] [Abstract][Full Text] [Related]
16. A randomized study comparing the effectiveness of microwave ablation radioimmunotherapy and postoperative adjuvant chemoradiation in the treatment of non-small cell lung cancer.
Zhao Z; Su Z; Zhang W; Luo M; Wang H; Huang L
J BUON; 2016; 21(2):326-32. PubMed ID: 27273941
[TBL] [Abstract][Full Text] [Related]
17. Influence of conformal radiotherapy technique on survival after chemoradiotherapy for patients with stage III non-small cell lung cancer in the National Cancer Data Base.
Sher DJ; Koshy M; Liptay MJ; Fidler MJ
Cancer; 2014 Jul; 120(13):2060-8. PubMed ID: 24692108
[TBL] [Abstract][Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
